Nucleus Diagnosys Llp Profile
Key Indicators
- Obligation of Contribution ₹ 30.00 K
as on 23-01-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 23-01-2024
- Satisfied Charges ₹ 1.00 Cr
as on 23-01-2024
About Nucleus Diagnosys Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 30.00 K as per MCA.
- CIN/LLPIN/FCRN
AAF-9057
- Incorporation Date
11 Mar 2016
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nucleus Diagnosys Llp offer?
Nucleus Diagnosys Llp offers a wide range of products and services, including Infusion Syringes & Supplies, Blood Collection Tubes, Water Testing Equipment, Nephelometer, Laboratory Centrifuge, Centrifuge Machine, Test Kits, Allergy Test Kit, Medical Laboratory Instruments, Pathology Lab Equipments.
Who are the key members and board of directors at Nucleus Diagnosys Llp?
Designated Partners(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandip Shah  | Designated Partner | 01-Dec-2022 | Current |
| Samirbhai Shah | Designated Partner | 11-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Nucleus Diagnosys Llp.
Enhance accessibility to Nucleus Diagnosys Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nucleus Diagnosys Llp?
Unlock access to Nucleus Diagnosys Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 29 Jul 2022 | ₹2.00 Cr | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 13 Aug 2019 | ₹1.50 M | Satisfied |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 20 Jun 2017 | ₹8.50 M | Satisfied |
How Many Employees Work at Nucleus Diagnosys Llp?
Nucleus Diagnosys Llp has a workforce of 25 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleus Diagnosys Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Diagnosys Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
